相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic Impact of Morphologic and Phenotypic Features of Childhood ALK-Positive Anaplastic Large-Cell Lymphoma: Results of the ALCL99 Study
Laurence Lamant et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk
Kamel Ait-Tahar et al.
BLOOD (2010)
Single-Drug Vinblastine As Salvage Treatment for Refractory or Relapsed Anaplastic Large-Cell Lymphoma: A Report From the French Society of Pediatric Oncology
Laurence Brugieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Impact of the Methotrexate Administration Dose on the Need for Intrathecal Treatment in Children and Adolescents With Anaplastic Large-Cell Lymphoma: Results of a Randomized Trial of the EICNHL Group
Laurence Brugieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL
L. Mussolin et al.
LEUKEMIA (2009)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prognostic factors in childhood anaplastic large cell lymphoma:: results of a large European intergroup study
Marie-Cecile Le Deley et al.
BLOOD (2008)
Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK-positive anaplastic large-cell lymphoma
Christine Damm-Welk et al.
BLOOD (2007)
Germline mutations of the perforin gene are a frequent occurrence in childhood anaplastic large cell lymphorna
Sonia Cannella et al.
CANCER (2007)
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant et al.
BLOOD (2007)
CD4 T-helper responses to the anaplastic lymphoma kinase (ALK) protein in patients with ALK-positive anaplastic large-cell lymphoma
Kamel Ait-Tahar et al.
CANCER RESEARCH (2007)
The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence
B Burkhardt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma
L Mussolin et al.
LEUKEMIA (2005)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma:: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90
K Seidemann et al.
BLOOD (2001)